Special Issue "Advance in Development of Patient-Centric Dosage Form"
Deadline for manuscript submissions: 10 August 2021.
Interests: medicine acceptability; patient-centric formulation; sustained release dosage form; solid dosage form
Interests: additive manufacturing (3D Printing & Bioprinting); drug delivery; electrospinning; microfluidics (micro/nano particle formulation & chip manufacturing); pharmaceutics
Special Issues and Collections in MDPI journals
Special Issue in Pharmaceutics: Nanotechnology Advances in Cancer Treatment
Special Issue in Materials: Polymeric Electrospun Nanofibers: Applications in Drug Delivery and Tissue Engineering
Special Issue in Polymers: Atomic Force Microscopy in Polymer Science
Special Issue in Pharmaceutics: 3D Printing of Pharmaceuticals and Drug Delivery Devices
Special Issue in Pharmaceutics: Recent Development of Electrospinning for Drug Delivery
Special Issue in Pharmaceutics: Recent Development of Electrospinning for Drug Delivery Volume II
Special Issue in Pharmaceutics: Microfluidics as a Tool for Drug Delivery
Topical Collection in Pharmaceutics: 3D Printing and Bioprinting Applications in Pharmaceutics
Special Issue in Pharmaceutics: Novel Nanoparticles for Targeted Delivery of Therapeutic Nucleic Acids
Special Issue in Molecules: Novel Formulations and Pharmaceutical Materials to Improve Therapeutic Outcomes for Patients. A Themed Issue Dedicated to Professor Ryan F. Donnelly
Special Issue in Coatings: Antimicrobial Coatings for Touch Surfaces and Air-Filters in the Wake of COVID-19
It is established that the medication acceptability of dosage forms could influence patient compliance and treatment efficacy and safety. Currently, research focuses on developing patient-centric formulations as personalized dosage forms where the product provides the benefits for individual patient needs. According to the World Health Organization (WHO), patient-centric formulations are becoming essential for public health when dealing with long-term diseases treated with multiple drugs. However, data related to the understanding of dosage form-related issues in medication acceptability are lacking. Therefore, the development of advanced technologies has resulted in significant efforts to develop customizable dosage forms.
The focus of this Special Issue of Pharmaceutics will be on assessing and identifying dosage form-related issues in medication acceptability and recent advances in the development of effective strategies to produce patient-centric dosage forms to improve acceptability. This Special Issue will accept both Reviews and Research articles.
Dr. Laura Modica de Mohac
Dr. Dimitrios A. Lamprou
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- medication acceptability
- patient-centric dosage forms
- solid dosage forms
- product customization